-
1
-
-
0033693277
-
Cerebrotendinous xanthomatosis: The spectrum of imaging findings and the correlation with neuropathologic findings
-
Barkhof F, Verrips A, Wesseling P et al (2000) Cerebrotendinous xanthomatosis: the spectrum of imaging findings and the correlation with neuropathologic findings. Radiology 217:869-876
-
(2000)
Radiology
, vol.217
, pp. 869-876
-
-
Barkhof, F.1
Verrips, A.2
Wesseling, P.3
-
2
-
-
0021784183
-
Effect of chenodeoxycholic acid on biliary and urinary bile acids and bile alcohols in cerebrotendinous xanthomatosis; monitoring by high performance liquid chromatography
-
Batta AK, Shefer S, Batta M, Salen G (1985) Effect of chenodeoxycholic acid on biliary and urinary bile acids and bile alcohols in cerebrotendinous xanthomatosis; monitoring by high performance liquid chromatography. J Lipid Res 26:690-698 (Pubitemid 15248941)
-
(1985)
Journal of Lipid Research
, vol.26
, Issue.6
, pp. 690-698
-
-
Batta, A.K.1
Shefer, S.2
Batta, M.3
Salen, G.4
-
3
-
-
0021707122
-
Long-term treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid
-
Berginer VM, Salen G, Shefer S (1984) Long-term treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid. N Engl J Med 311:1649-1652 (Pubitemid 15183994)
-
(1984)
New England Journal of Medicine
, vol.311
, Issue.26
, pp. 1649-1652
-
-
Berginer, V.M.1
Salen, G.2
Shefer, S.3
-
4
-
-
0027475911
-
Osteoporosis and increased bone fractures in cerebrotendinous xanthomatosis
-
DOI 10.1016/0026-0495(93)90174-M
-
Berginer VM, Shany S, Alkalay D et al (1993) Osteoporosis and increased bone fractures in cerebrotendinous xanthomatosis. Metabolism 42:69-74 (Pubitemid 23019935)
-
(1993)
Metabolism: Clinical and Experimental
, vol.42
, Issue.1
, pp. 69-74
-
-
Berginer, V.M.1
Shany, S.2
Alkalay, D.3
Berginer, J.4
Dekel, S.5
Salen, G.6
Tint, G.S.7
Gazit, D.8
-
5
-
-
59449087114
-
Chronic diarrhea and juvenile cataracts: Think cerebrotendinous xanthomatosis and treat
-
Berginer VM, Gross B, Morad K et al (2009) Chronic diarrhea and juvenile cataracts: think cerebrotendinous xanthomatosis and treat. Pediatrics 123:143-147
-
(2009)
Pediatrics
, vol.123
, pp. 143-147
-
-
Berginer, V.M.1
Gross, B.2
Morad, K.3
-
6
-
-
77952304021
-
Cerebrotendinous xanthomatosis: An inborn error in bile acid synthesis with defined mutations but still a challenge
-
Björkhem I, Hansson M (2010) Cerebrotendinous xanthomatosis: an inborn error in bile acid synthesis with defined mutations but still a challenge. Biochem Biophys Res Commun 396:46-49
-
(2010)
Biochem Biophys Res Commun
, vol.396
, pp. 46-49
-
-
Björkhem, I.1
Hansson, M.2
-
7
-
-
0025868097
-
Characterization of human sterol 27-hydroxylase: A mitochondrial cytochrome P-450 that catalyzes multiple oxidation reactions in bile acid biosynthesis
-
Cali JJ, Russell DW (1991) Characterization of human sterol 27-hydroxylase. A mitochondrial cytochrome P-450 that catalyzes multiple oxidation reaction in bile acid biosynthesis. J Biol Chem 266:7774-7778 (Pubitemid 21906433)
-
(1991)
Journal of Biological Chemistry
, vol.266
, Issue.12
, pp. 7774-7778
-
-
Cali, J.J.1
Russell, D.W.2
-
8
-
-
12244306965
-
Mutations in the sterol 27-hydroxylase gene (CYP27A) cause hepatitis of infancy as well as cerebrotendinous xanthomatosis
-
DOI 10.1023/A:1021211520034
-
Clayton PT, Verrips A, Sistermans E, Mann A, Mieli-Vergani G, Wevers R (2002) Mutations in the sterol 27-hydroxylase gene (CYP27A) cause hepatitis of infancy as well as cerebrotendinous xanthomatosis. J Inherit Metab Dis 25:501-513 (Pubitemid 36104385)
-
(2002)
Journal of Inherited Metabolic Disease
, vol.25
, Issue.6
, pp. 501-513
-
-
Clayton, P.T.1
Verrips, A.2
Sistermans, E.3
Mann, A.4
Mieli-Vergani, G.5
Wevers, R.6
-
9
-
-
64449083900
-
Children with cataract and chronic diarrhoea: Cerebrotendinous xanthomatosis
-
Cruysberg JR (2009) Children with cataract and chronic diarrhoea: cerebrotendinous xanthomatosis. J Inherit Metab Dis 32:309
-
(2009)
J Inherit Metab Dis
, vol.32
, pp. 309
-
-
Cruysberg, J.R.1
-
10
-
-
0025936676
-
Juvenile cataract associated with chronic diarrhea in pediatric cerebrotendinous xanthomatosis
-
Cruysberg JR, Wevers RA, Tolboom JJ (1991) Juvenile cataract associated with chronic diarrhea in pediatric cerebrotendinous xanthomatosis. Am J Ophthalmol 112:606-607
-
(1991)
Am J Ophthalmol
, vol.112
, pp. 606-607
-
-
Cruysberg, J.R.1
Wevers, R.A.2
Tolboom, J.J.3
-
11
-
-
0035188015
-
Magnetic resonance imaging and spectroscopic changes in brains of patients with cerebrotendinous xanthomatosis
-
De Stefano N, Dotti MT, Mortilla M, Federico A (2001) Magnetic resonance imaging and spectroscopic changes in brains of patients with cerebrotendinous xanthomatosis. Brain 124:121-131 (Pubitemid 32055994)
-
(2001)
Brain
, vol.124
, Issue.1
, pp. 121-131
-
-
De Stefano, N.1
Dotti, M.T.2
Mortilla, M.3
Federico, A.4
-
13
-
-
0141997295
-
Cerebrotendinous xanthomatosis: Clinical manifestations, diagnostic criteria, pathogenesis, and therapy
-
Federico A, Dotti MT (2003) Cerebrotendinous xanthomatosis: clinical manifestations, diagnostic criteria, pathogenesis, and therapy. J Child Neurol 18:633-638 (Pubitemid 37258469)
-
(2003)
Journal of Child Neurology
, vol.18
, Issue.9
, pp. 633-638
-
-
Federico, A.1
Dotti, M.T.2
-
14
-
-
84901887818
-
Psychiatric manifestations in cerebrotendinous xanthomatosis
-
doi:10.1038/tp.2013.76
-
Fraidakis MJ (2013) Psychiatric manifestations in cerebrotendinous xanthomatosis. Transl Psychiatry 3:e302. doi:10.1038/tp.2013.76
-
(2013)
Transl Psychiatry
, vol.3
-
-
Fraidakis, M.J.1
-
15
-
-
84872362010
-
Polyneuropathy in cerebrotendinous xanthomatosis and response to treatment with chenodeoxycholic acid
-
Ginanneschi F, Mignarri A, Mondelli M et al (2013) Polyneuropathy in cerebrotendinous xanthomatosis and response to treatment with chenodeoxycholic acid. J Neurol 260:268-274
-
(2013)
J Neurol
, vol.260
, pp. 268-274
-
-
Ginanneschi, F.1
Mignarri, A.2
Mondelli, M.3
-
16
-
-
0022347684
-
Bile acid therapies applied to patients suffering from cerebrotendinous xanthomatosis
-
DOI 10.1016/0009-8981(85)90182-2
-
Koopman BJ, Wolthers BG, van der Molen JC, Waterreus RJ (1985) Bile acid therapies applied to patients suffering from cerebrotendinous xanthomatosis. Clin Chim Acta 152:115-122 (Pubitemid 16233196)
-
(1985)
Clinica Chimica Acta
, vol.152
, Issue.1-2
, pp. 115-122
-
-
Koopman, B.J.1
Wolthers, B.G.2
Van Der, M.J.C.3
Waterreus, R.J.4
-
17
-
-
0035089564
-
Fine-mapping, mutation analyses, and structural mapping of cerebrotendinous xanthomatosis in U.S. pedigrees
-
Lee MH, Hazard S, Carpten JD et al (2001) Fine-mapping, mutation analyses, and structuralmapping of cerebrotendinous xanthomatosis in U.S. pedigrees. J Lipid Res 42:159-169 (Pubitemid 32206826)
-
(2001)
Journal of Lipid Research
, vol.42
, Issue.2
, pp. 159-169
-
-
Lee, M.-H.1
Hazard, S.2
Carpten, J.D.3
Yi, S.4
Cohen, J.5
Gerhardt, G.T.6
Salen, G.7
Patel, S.B.8
-
18
-
-
25144451226
-
Cerebrotendinous xanthomatosis: Possible higher prevalence than previously recognized
-
DOI 10.1001/archneur.62.9.1459
-
Lorincz MT, Rainier S, Thomas D, Fink JK (2005) Cerebrotendinous xanthomatosis: possible higher prevalence than previously recognized. Arch Neurol 62:1459-1463 (Pubitemid 41352065)
-
(2005)
Archives of Neurology
, vol.62
, Issue.9
, pp. 1459-1463
-
-
Lorincz, M.T.1
Rainier, S.2
Thomas, D.3
Fink, J.K.4
-
19
-
-
84873744151
-
Long-term bone density evaluation in cerebrotendinous xanthomatosis: Evidence of improvement after chenodeoxycholic acid treatment
-
Martini G, Mignarri A, Ruvio M et al (2013) Long-term bone density evaluation in cerebrotendinous xanthomatosis: evidence of improvement after chenodeoxycholic acid treatment. Calcif Tissue Int 92:282-286
-
(2013)
Calcif Tissue Int
, vol.92
, pp. 282-286
-
-
Martini, G.1
Mignarri, A.2
Ruvio, M.3
-
20
-
-
79960029352
-
Clinical relevance and neurophysiological correlates of spasticity in cerebrotendinous xanthomatosis
-
Mignarri A, Rossi S, Ballerini M et al (2011) Clinical relevance and neurophysiological correlates of spasticity in cerebrotendinous xanthomatosis. J Neurol 258:783-790
-
(2011)
J Neurol
, vol.258
, pp. 783-790
-
-
Mignarri, A.1
Rossi, S.2
Ballerini, M.3
-
21
-
-
84862862497
-
Cerebrotendinous xanthomatosis with progressive cerebellar vacuolation: Six-year MRI follow-up
-
Mignarri A, Dotti MT, Del Puppo M et al (2012a) Cerebrotendinous xanthomatosis with progressive cerebellar vacuolation: six-year MRI follow-up. Neuroradiology 54:649-651
-
(2012)
Neuroradiology
, vol.54
, pp. 649-651
-
-
Mignarri, A.1
Dotti, M.T.2
Del Puppo, M.3
-
22
-
-
84655161937
-
Parkinsonism as neurological presentation of late-onset cerebrotendinous xanthomatosis
-
Mignarri A, Falcini M, Vella A et al (2012b) Parkinsonism as neurological presentation of late-onset cerebrotendinous xanthomatosis. Parkinsonism Relat Disord 18:99-101
-
(2012)
Parkinsonism Relat Disord
, vol.18
, pp. 99-101
-
-
Mignarri, A.1
Falcini, M.2
Vella, A.3
-
23
-
-
0025895604
-
Combined treatment with chenodeoxycholic acid and pravastatin improves plasma cholestanol levels associated with marked regression of tendon xanthomas in cerebrotendinous xanthomatosis
-
Nakamura T, Matsuzawa Y, Takemura K, Kubo M, Miki H, Tarui S (1991) Combined treatment with chenodeoxycholic acid and pravastatin improves plasma cholestanol levels associated with marked regression of tendon xanthomas in cerebrotendinous xanthomatosis. Metabolism 40:741-746
-
(1991)
Metabolism
, vol.40
, pp. 741-746
-
-
Nakamura, T.1
Matsuzawa, Y.2
Takemura, K.3
Kubo, M.4
Miki, H.5
Tarui, S.6
-
24
-
-
82955223520
-
Prospective treatment of cerebrotendinous xanthomatosis with cholic acid therapy
-
Pierre G, Setchell K, Blyth J, Preece MA, Chakrapani A, McKiernan P (2008) Prospective treatment of cerebrotendinous xanthomatosis with cholic acid therapy. J Inherit Metab Dis 31:S241-S245
-
(2008)
J Inherit Metab Dis
, vol.31
-
-
Pierre, G.1
Setchell, K.2
Blyth, J.3
Preece, M.A.4
Chakrapani, A.5
McKiernan, P.6
-
26
-
-
80052806070
-
Cerebrotendinous xanthomatosis in Spain: Clinical, prognostic, and genetic survey
-
Pilo de la Fuente B, Jimenez-Escrig A, Lorenzo JR et al (2011a) Cerebrotendinous xanthomatosis in Spain: clinical, prognostic, and genetic survey. Eur J Neurol 18:1203-1211
-
(2011)
Eur J Neurol
, vol.18
, pp. 1203-1211
-
-
Pilo De La Fuente, B.1
Jimenez-Escrig, A.2
Lorenzo, J.R.3
-
27
-
-
79961166408
-
Usefulness of cholestanol levels in the diagnosis and follow-up of patients with cerebrotendinous xanthomatosis
-
Pilo de la Fuente B, Sobrido MJ, Girós M et al (2011b) Usefulness of cholestanol levels in the diagnosis and follow-up of patients with cerebrotendinous xanthomatosis. Neurologia 26:397-404
-
(2011)
Neurologia
, vol.26
, pp. 397-404
-
-
Pilo De La Fuente, B.1
Sobrido, M.J.2
Girós, M.3
-
28
-
-
79953049062
-
Neurophysiological study in cerebrotendinous xanthomatosis
-
Pilo B, de Blas G, Sobrido MJ et al (2011) Neurophysiological study in cerebrotendinous xanthomatosis. Muscle Nerve 43:531-536
-
(2011)
Muscle Nerve
, vol.43
, pp. 531-536
-
-
Pilo, B.1
De Blas, G.2
Sobrido, M.J.3
-
29
-
-
84871793065
-
Atypical parkinsonism and cerebrotendinous xanthomatosis: Report of a family with corticobasal syndrome and a literature review
-
Rubio-Agusti I, Kojovic M, Edwards MJ et al (2012) Atypical parkinsonism and cerebrotendinous xanthomatosis: report of a family with corticobasal syndrome and a literature review. Mov Disord 27:1769-1774
-
(2012)
Mov Disord
, vol.27
, pp. 1769-1774
-
-
Rubio-Agusti, I.1
Kojovic, M.2
Edwards, M.J.3
-
30
-
-
0023265331
-
Increased concentrations of cholestanol and apolipoprotein B in the cerebrospinal fluid of patients with cerebrotendinous xanthomatosis. Effect of chenodeoxycholic acid
-
Salen G, Berginer V, Shore V et al (1987) Increased concentrations of cholestanol and apolipoprotein B in the cerebrospinal fluid of patients with cerebrotendinous xanthomatosis. Effect of chenodeoxycholic acid. N Engl J Med 316:1233-1238 (Pubitemid 17069352)
-
(1987)
New England Journal of Medicine
, vol.316
, Issue.20
, pp. 1233-1238
-
-
Salen, G.1
Berginer, V.2
Shore, V.3
-
31
-
-
0028075336
-
Comparative effects of lovastatin and chenodeoxycholic acid on plasma cholestanol levels and abnormal bile acid metabolism in cerebrotendinous xanthomatosis
-
DOI 10.1016/0026-0495(94)90183-X
-
Salen G, Batta AK, Tint GS, Shefer S (1994) Comparative effects of lovastatin and chenodeoxycholic acid on plasma cholestanol levels and abnormal bile acid metabolism in cerebrotendinous xanthomatosis. Metabolism 43:1018-1022 (Pubitemid 24249405)
-
(1994)
Metabolism: Clinical and Experimental
, vol.43
, Issue.8
, pp. 1018-1022
-
-
Salen, G.1
Batta, A.K.2
Tint, G.S.3
Shefer, S.4
-
32
-
-
85086351538
-
Chenodeoxycholic treatment of cerebrotendinous xanthomatosis
-
Samenuk P, Koffman BM (2001) Chenodeoxycholic treatment of cerebrotendinous xanthomatosis. Neurology 56:695-696
-
(2001)
Neurology
, vol.56
, pp. 695-696
-
-
Samenuk, P.1
Koffman, B.M.2
-
33
-
-
33645090933
-
Could steroids mask the diagnosis of cerebrotendinous xanthomatosis?
-
Siman-Tov T, Meiner V, Gadoth N (2006) Could steroids mask the diagnosis of cerebrotendinous xanthomatosis? J Neurol Sci 243:83-86
-
(2006)
J Neurol Sci
, vol.243
, pp. 83-86
-
-
Siman-Tov, T.1
Meiner, V.2
Gadoth, N.3
-
34
-
-
77949519798
-
Cerebrotendinous xanthomatosis patients with and without parkinsonism: Clinical characteristics and neuroimaging findings
-
Su CS, Chang WN, Huang SH et al (2010) Cerebrotendinous xanthomatosis patients with and without parkinsonism: clinical characteristics and neuroimaging findings. Mov Disord 25:452-458
-
(2010)
Mov Disord
, vol.25
, pp. 452-458
-
-
Su, C.S.1
Chang, W.N.2
Huang, S.H.3
-
35
-
-
0031955919
-
Treatment and follow-up of children with cerebrotendinous xanthomatosis
-
DOI 10.1007/s004310050818
-
Van Heijst AF, Verrips A, Wevers RA, Cruysberg JR, Renier WO, Tolboom JJ (1998) Treatment and follow-up of children with cerebrotendinous xanthomatosis. Eur J Pediatr 157:313-316 (Pubitemid 28178134)
-
(1998)
European Journal of Pediatrics
, vol.157
, Issue.4
, pp. 313-316
-
-
Van Heijst, A.F.J.1
Verrips, A.2
Wevers, R.A.3
Cruysberg, J.R.M.4
Renier, W.O.5
Tolboom, J.J.M.6
-
36
-
-
13044264478
-
Effect of simvastatin in addition to chenodeoxycholic acid in patients with cerebrotendinous xanthomatosis
-
DOI 10.1016/S0026-0495(99)90040-9
-
Verrips A, Wevers RA, Van Engelen BG et al (1999) Effect of simvastatin in addition to chenodeoxycholic acid in patients with cerebrotendinous xanthomatosis. Metabolism 48:233-238 (Pubitemid 29072281)
-
(1999)
Metabolism: Clinical and Experimental
, vol.48
, Issue.2
, pp. 233-238
-
-
Verrips, A.1
Wevers, R.A.2
Van Engelen, B.G.M.3
Keyser, A.4
Wolthers, B.G.5
Barkhof, F.6
Stalenhoef, A.7
De Graaf, R.8
Janssen-Zijlstra, F.9
Van Spreeken, A.10
Gabreels, F.J.M.11
-
37
-
-
0034048587
-
Clinical and molecular genetic characteristics of patients with cerebrotendinous xanthomatosis
-
Verrips A, Hoefsloot LH, Steenbergen GC et al (2000a) Clinical and molecular genetic characteristics of patients with cerebrotendinous xanthomatosis. Brain 23:908-919 (Pubitemid 30224187)
-
(2000)
Brain
, vol.123
, Issue.5
, pp. 908-919
-
-
Verrips, A.1
Hoefsloot, L.H.2
Steenbergen, G.C.H.3
Theelen, J.P.4
Wevers, R.A.5
Gabreels, F.J.M.6
Van Engelen, B.G.M.7
Van Den, H.L.P.W.J.8
-
38
-
-
0034036188
-
Presence of diarrhea and absence of tendon xanthomas in patients with cerebrotendinous xanthomatosis
-
Verrips A, van Engelen BG, Wevers RA et al (2000b) Presence of diarrhea and absence of tendon xanthomas in patients with cerebrotendinous xanthomatosis. Arch Neurol 57:520-524 (Pubitemid 30212126)
-
(2000)
Archives of Neurology
, vol.57
, Issue.4
, pp. 520-524
-
-
Verrips, A.1
Van Engelen, B.G.M.2
Wevers, R.A.3
Van Geel, B.M.4
Cruysberg, J.R.M.5
Van Den, H.L.P.W.J.6
Keyser, A.7
Gabreels, F.J.M.8
-
39
-
-
16844368489
-
Mutation in the sterol 27-hydroxylase gene associated with fatal cholestasis in infancy
-
DOI 10.1097/01.MPG.0000150419.23031.2A
-
von Bahr S, Björkhem I, Van't Hooft F et al (2005) Mutation in the sterol 27-hydroxylase gene associated with fatal cholestasis in infancy. J Pediatr Gastroenterol Nutr 40:481-486 (Pubitemid 40489578)
-
(2005)
Journal of Pediatric Gastroenterology and Nutrition
, vol.40
, Issue.4
, pp. 481-486
-
-
Von Bahr, S.1
Bjorkhem, I.2
Van't, H.F.3
Alvelius, G.4
Nemeth, A.5
Sjovall, J.6
Fischler, B.7
-
40
-
-
84878827771
-
Neurological outcome in cerebrotendinous xanthomatosis treated with chenodeoxycholic Acid: Early versus late diagnosis
-
Yahalom G, Tsabari R, Molshatzki N, Ephraty L, Cohen H, Hassin-Baer S (2013) Neurological outcome in cerebrotendinous xanthomatosis treated with chenodeoxycholic Acid: early versus late diagnosis. Clin Neuropharmacol 36:78-83
-
(2013)
Clin Neuropharmacol
, vol.36
, pp. 78-83
-
-
Yahalom, G.1
Tsabari, R.2
Molshatzki, N.3
Ephraty, L.4
Cohen, H.5
Hassin-Baer, S.6
|